Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
---|---|---|---|---|---|---|
|
body weight
with high-fat high-sucrose diet |
Weekly. | DO population | both | 4-26wks | 2018 |
|
body weight
with high-fat diet |
8-29 wks of age. | BXD w/par (57) | m | 8-29 wks | 2016 |
|
body weight
with high-fat diet |
inbred w/CC8 | both | 8-21 wks | 2021 | |
|
body weight | Body weight | inbred (13) | m | 7-8wks | 2011 |
|
body weight | Body weight and growth curve from 4wks to 26wks weighed monthly. | ILSXISS (97) | f | 6wks | 2005 |
|
body weight | Body weight | both | 8-20wks | 2021 | |
|
body weight
with influenza A (H5N1) virus |
Influenza A (H5N1) virus (several doses) vs. baseline. | inbred (23) | f | 6-9wks | 2011 |
|
body weight
with Theiler's murine encephalomyelitis virus |
Body weight | CC (5) | both | 4wks | 2017 |
|
body weight | Body weight | inbred (14) | both | 10wks | 2004 |
|
body weight | Body weight | CC diallel w/par (62) | both | 8-16wks | 2012 |
|
body weight | Body weight | DO population w/par (9) | both | 12-16wks | 2013 |
|
body weight
with high-fat diet |
Body weight and growth curve from age 1wk to 22wks (pre-wean, post-wean, adult). High-fat diet (17wks) vs. control. | LGXSM w/par (19) | both | 12-16wks | 2004 |
|
body weight
with ethanol |
Body weight | inbred (8) | both | 8wks | 2003 |
|
body weight
with ethanol |
Body weight | inbred (22) | both | 9-17wks | 2003 |
|
body weight
with haloperidol |
Baseline vs. after haloperidol 60d implant. | inbred w/CC8 (27) | m | 9-28wks | 2012 |
|
body weight | Body weight | BXD w/par (55) | both | 10-16wks | 2018 |
|
body weight | Body weight | inbred (13) | both | 10wks | 2004 |
|
body weight | Body weight | BXD w/par (66) | both | 10wks | 2010 |
|
body weight | Pup body weight at day 3. | inbred (15) | f | 6-8wks | 2010 |
|
body weight | Pup body weight at day 3. | B6.A consomic w/par (22) | f | 6-8wks | 2010 |
|
body weight | Body weight | inbred (10) | both | 16wks | 2004 |
|
body weight | Body weight | inbred (14) | both | 9-12wks | 2003 |
|
body weight | Body weight | inbred (14) | both | 25wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Body weight | CC pre w/par (163) | f | 8-16wks | 2012 |
|
body weight | Body weight and growth curve from 8wks to 21wks. | inbred w/CC8 (8) | both | 8-21wks | 2020 |
|
body weight
with West Nile virus |
Body weight | CC RIX (5) | m | 8-10wks | 2015 |
|
body weight | Body weight of newborns. | inbred (8) | both | postnatal | 2011 |
|
body weight | Body weight of newborns. | BXH (10) | both | postnatal | 2011 |
|
body weight | Daily body weight gain of cross-fostered pups. | inbred (31) | f | 14-18wks | 2012 |
|
body weight | Body weight | DO population | both | 8-60 wks | 2020 |
|
body weight | Body weight | inbred (14) | m | 8-10wks | 2010 |
|
body weight
with isoniazid |
Body weight. Isoniazid-treated vs. control. | inbred (34) | f | 8-10wks | 2011 |
|
body weight
with DB289 |
DB289-treated vs. control. | inbred (34) | f | 6-8wks | 2012 |
|
body weight | Various interventions vs. controls. | UM-HET3 population | both | various | 2004-2023 |
|
body weight | Body weight and growth curve from age 3wks to 10 wks, weighed weekly. | inbred (24) | both | 8wks | 2000 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight and growth curve from age 3wks to 16wks, weighed weekly. | inbred (10) | both | 3-16wks | 2014 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (7) | both | 8-14wks | 2003 |
|
body weight | Body weight | inbred w/CC8 (62) | both | 8-14wks | 2021 |
|
body weight | Body weight | CC pre (31) | both | 8-14wks | 2015 |
|
body weight | Body weight | inbred (41) | both | 8-9wks | 2010 |
|
body weight
with exercise |
Exercise (swim endurance training regimen) vs. control at weekly intervals for 5wks. | inbred (6) | m | 11-14wks | 2012 |
|
body weight | Body weight | CC (16) | both | 10wks | 2015 |
|
body weight | Body weight | inbred (34) | both | 8wks | 2012 |
|
body weight
with exercise |
Baseline vs. after exercise (access to running wheel). | CC pre w/par (184) | m | 10-12wks | 2011 |
|
body weight
with atenolol, isoproterenol |
Isoproterenol or atenolol vs. control. | inbred (23) | m | 10-12wks | 2009 |
|
body weight | Body weight | CC (50) | f | 17-72wks | 2017 |
|
body weight | Body weight before, during, and after several weeks of exercise. | CC (43) | f | 20-88wks | 2017 |
|
body weight
with exercise |
Body weight before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
body weight
with exercise |
Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
body weight
with ethanol |
Body weight | inbred (15) | m | 8-11wks | 2005 |
|
body weight | Body weight | CC (52) | m | 7-20wks | 2018 |
|
body weight
with high-fat diet and olanzapine |
Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). | inbred w/CC8 (9) | f | 8-18wks | 2014 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 12wks. | B6.A consomic w/par (24) | m | 5, 17 wks | 2008 |
|
body weight
with high-fat high-sucrose diet |
After 16 wks on high-fat high-sucrose diet. | inbred (2) | m | 21 wks | 2016 |
|
body weight
with high-fat high-sucrose diet |
High-fat high-sucrose diet for 14-15 wks | B6.A consomic w/par (3) | m | 4-19 wks | 2016 |
|
body weight
with high-fat diet |
High-fat diet for 8wks. | inbred w/CC7 (43) | both | 5, 21 wks | 2003 |
|
body weight
with restricted diet |
Restricted diet vs. ad libitum diet. | ILSXISS (44) | both | max lifespan | 2010 |
|
body weight | Measured every 2 mo, starting at age 2 mo to 16 mo. | F1 AD-BXD (55) | both | 7-65wks | 2019 |
|
body weight | Body weight | inbred (8) | m | 10-66wks | 2015 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | inbred (44) | both | 15-19wks | 2000 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | obesity mutants (8) | both | 15-19wks | 2000 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
body weight | Body weight | inbred (32) | m | 7-9wks | 2007 |
|
body weight
with exercise |
Exercise wheel group vs. control group. | inbred (12) | both | 8-15wks | 2010 |
|
study archive
with tetrachloroethylene |
Toxicokinetics and toxicodynamics of tetrachloroethylene exposure. | CC (45) | both | 2016 | |
|
body weight
with various diets |
Body weight at weaning and time of test. Comparison of 4 diets. | CC RIX (18) | f | 8-9 wks | 2018 |
|
body weight | Body weight | inbred (11) | both | 8-10wks | 2005 |
|
body weight
with high-fat diet |
At 8, 20 and 29 wks of age. | BXD w/par (36) | m | 8-29 wks | 2022 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints. | inbred (9) | both | 10-12wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints.. | BXD w/par (56) | f | 9-18wks | 2012 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. | inbred w/CC8 (8) | both | 7-13wks | 2013 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight | Body weight | inbred (7) | both | 9-18wks | 2000 |
|
body weight | Body weight | inbred (16) | both | 7-9wks | 2001 |
|
body weight
with high-fat diet |
High-fat diet for 4wks vs. control. | inbred (10) | both | 10-13wks | 2008 |
|
body weight | Body weight | CC (12) | m | 15-33wks | 2020 |
|
body weight | Body weight | CC RIX (28) | m | 7-44wks | 2020 |
|
body weight | Body weight | DO population | m | 12-15wks | 2020 |
|
body weight
with selenium |
Body weight curve 3 to 12 wks, control group. | inbred w/CC8 (8) | m | 3-14wks | 2018 |
|
body weight
with cocaine |
Body weight | inbred (45) | m | 8-11wks | 2015 |
|
body weight | Body weight during testing. | inbred (28) | m | 9wks | 2001 |
|
body weight | Body weight | inbred (28) | m | 4-12wks | 2001 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 9-15wks | 2002 |
|
body weight | Body weight | ILSXISS (43) | both | 8-23wks | 2015 |
|
body weight | Body weight | inbred (21) | both | 6-8wks | 2009 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 5-6wks | 2002 |
|
body weight | Body weight | CC RIX (73) | both | 7-13wks | 2020 |
|
body weight
with arsenic |
Baseline, then after iAs exposure for 26 wks | DO population | m | 4-34 wks | 2022 |
|
body weight | Aging study, 6mo, 12mo, and 18mo. | inbred (33) | both | 26, 52, 78 wks | 2007 |
|
body weight | inbred (30) | both | 7-15 wks | 2020 |